Presented by
Joseph Kim,
VP and Chief Marketing Officer for ProofPilot
Joseph Kim brings over 23 years of pharmaceutical research expertise including a leadership role in Lilly’s Digital Health Office and as Chief Marketing Officer at ProofPilot. His industry knowledge across all phases of clinical research draws on experiences with Shire and Merck, CROs and technology vendors. His well-known history of innovation in the industry was recognized by the “Top 100 individuals on the 2015 MedicineMakers Power List”
Joseph Schenk,
CEO at Quality Bridge
Joseph has over 30 years of quality improvement, computer validation and project management experience working for FDA regulated (GxP) processes. He has conducted 175+ audits of CROs, software vendors and other GxP suppliers.
Jay Turpen,
Head of Client Services with Diligent Pharma
Jay leads a team of staff and Auditors that implement a risk-based qualification service for clients of Diligent Pharma. He has been in the pharmaceutical industry for 32 years and has held various leadership roles. Jay has a wealth of experience in GMP, GLP, and GCP environments with significant real-life experience in developing numerous new drug candidates.
Jennifer Sessions,
Senior Director, Diligent Pharma
Jennifer has over 20 years of experience in clinical research, mostly with Eli Lilly and Company. Most recently, she served as the CEO of Cynvec, a private biotech company focused on cancer therapies.
